197 related articles for article (PubMed ID: 12042012)
1. Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator.
Garcia-Moran E; Mont L; Cuesta A; Matas M; Brugada J
Eur Heart J; 2002 Jun; 23(11):901-7. PubMed ID: 12042012
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
[TBL] [Abstract][Full Text] [Related]
3. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation].
Vacca M; Mont L; Valentino M; Sambola A; Madariaga R; Matas M; Brugada J
Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653
[TBL] [Abstract][Full Text] [Related]
4. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
8. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
Osswald S; Candinas R; Fuhrer J
Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
10. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
11. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
12. Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia.
Abello M; Merino JL; Peinado R; Gnoatto M; Arias MA; Gonzalez-Vasserot M; Sobrino JA
Eur Heart J; 2006 Jan; 27(1):89-95. PubMed ID: 16183691
[TBL] [Abstract][Full Text] [Related]
13. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe].
Priori SG; Paganini V; Boccalatte L; Schwartz PJ
G Ital Cardiol; 1995 Feb; 25(2):149-58. PubMed ID: 7642019
[TBL] [Abstract][Full Text] [Related]
15. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
17. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
19. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
Kozák M; Krivan L; Semrád B
Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
[TBL] [Abstract][Full Text] [Related]
20. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
